Tevogen Bio Holdings Inc. is a clinical-stage biotechnology firm dedicated to developing "off-the-shelf" precision T cell therapies for conditions across virology, oncology, and neurology.
52W Range
7thpctl
Volume
0.11×avg
Market Cap
28.69MUSD
P/E Ratio
-1.2TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
Tevogen Bio Holdings Inc.
TVGNNASDAQ Global Market·USD·Closed
Tevogen Bio Holdings Inc.
TVGNNASDAQ·USD·Closed
$6.89
+2.07%
$6.89
+$0.14 (2.07%)
52W Range
7thpctl
Volume
0.11×avg
Mkt Cap
28.69MUSD
P/E
-1.2TTM
Div Yield
–ann
TVGN: Tevogen Bio Holdings Inc. Stock Analysis | finqOS
